advertising

News

Judge backs Lilly in Novo lawsuit over weight-loss drug ads

A US judge has blocked Novo's request for an injunction on Eli Lilly's advertising for weight-loss and diabetes drugs Mounjaro and Zepbound.

News

Graphic of faceless person with board in front of them reading Coming Soon on orange background

UK watchdog takes first action on oral weight drug adverts

Online pharmacies operating in the UK breached Advertising Standards Authority rules by promoting oral weight drugs to the public.

News

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.

News

ImmunityBio warned by FDA over 'misleading' Anktiva content

The FDA has sent a warning letter to ImmunityBio over "false and misleading" comments made by executive chair, billionaire Patrick Soon-Shiong.

News

FDA ramps up its pushback against compounded GLP-1s

In a move that will please Novo Nordisk and Eli Lilly, the FDA sent warnings to 30 telehealth firms, accusing them of illegally marketing GLP-1 drugs.

News

Novo Nordisk's Wegovy pill ad 'misleading', says FDA

Novo Nordisk has been criticised by the FDA for a TV ad for the Wegovy pill, which the agency claims makes "false and misleading" claims.

Judge backs Lilly in Novo lawsuit over weight-loss drug ads

UK watchdog takes first action on oral weight drug adverts

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

ImmunityBio warned by FDA over 'misleading' Anktiva content

FDA ramps up its pushback against compounded GLP-1s

Novo Nordisk's Wegovy pill ad 'misleading', says FDA

Dren Bio pockets $350m for rare blood cancer programme

Discover a new era of healthcare panel engagement: Grounded ...

advertising

Editor's Picks